LOCALLY ADVANCED RECTAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED RECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED RECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study is for people with a certain type of advanced rectal cancer called HER2-positive. Researchers are testing whether adding two targeted drugs, tucatinib and trastuzumab, to standard chemotherapy can shrink tumors more effectively before surgery or radiation. About 37 adu…
Matched conditions: LOCALLY ADVANCED RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
Immunotherapy duo shows promise for tough rectal cancers
Disease control Recruiting nowThis study tests two immunotherapy drugs, botensilimab and balstilimab, in people with a type of rectal cancer that is harder to treat (called MMRp/MSS). The goal is to see if this combination can shrink or eliminate tumors before standard treatments like chemotherapy. About 40 a…
Matched conditions: LOCALLY ADVANCED RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC